HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Targeted Oncology

Targeted Oncology

Targeted oncology, a promising field within cancer research, focuses on treatments tailored to individual patients based on their genetic makeup, tumor characteristics, and other factors. This personalized approach offers the potential for more effective and less toxic therapies compared to traditional treatments. Targeted therapies often involve drugs that specifically target molecules involved in cancer growth and progression, such as certain proteins or genetic mutations. Advancements in genomics and molecular biology have facilitated the development of these therapies, allowing oncologists to better match treatments to the unique molecular profiles of patients' tumors. As research in targeted oncology continues to evolve, it holds great promise for improving outcomes and quality of life for cancer patients.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp